CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Wuhan Kangfude Biotechnology Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Wuhan Kangfude Biotechnology Co Ltd
Phone: +86 2759376891p:+86 2759376891 WUHAN, HUB  430000  China Fax: +86 2759376893f:+86 2759376893
Business Summary
BRIEF: For the fiscal year ended 31 December 2013, WuhanKangfude Biotechnology Co Ltd revenues increased 37% toRMB6.5M. Net income totaled RMB1.4M vs. loss of RMB319K.Revenues reflect an increase in demand for the Company'sproducts and services due to favorable market conditions.Net Income reflects Non - Operating Income increase fromRMB565K to RMB1.3M (income), Depreciation in GA decrease of29% to RMB18K (expense).

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/201312/31/2013Yes----

Industries
SIC Code Description
8731 Commercial physical and biological research

General Information
Outstanding Shares: 5,000,000 (As of 12/31/2013)
Fax Number: +86 2759376893


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, July 21, 2023